The Promise of Agonist Peptides

Agonist peptides coupled with non-invasive imaging could be the key to overcoming cancer resistance to immunotherapy.

Immune activating peptide agonists are promising antitumor agents for cancer patients who are unresponsive to immunotherapy. Together with non-invasive imaging, peptide agonists are a powerful strategy for targeted treatment and therapeutic efficacy monitoring. In this webinar, David Piwnica-Worms will talk about the potential of agonist peptides to overcome immunotherapy resistance through their ability to elicit lasting antitumor responses. 

Topics to be covered

  • Using agonist peptides to improve cancer immunotherapy
  • Non-invasive molecular imaging strategies to interrogate signal transduction and cell trafficking 

Wednesday, March 29th, 2023 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.


David R. Piwnica-Worms, MD, PhD

David Piwnica-Worms, MD, PhD 

The University of Texas MD Anderson Cancer Center 

Supported by